China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
28.30
+0.18 (0.64%)
Jul 31, 2026, 3:00 PM CST

SHA:600511 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
53,31152,46850,59749,69645,49946,469
Revenue Growth
4.15%3.70%1.81%9.22%-2.09%15.08%
Gross Profit
3,4783,4543,5943,9923,8173,621
Operating Income
2,0212,0262,1052,3722,3192,055
Net Income
2,0121,9972,0002,1461,9641,754
Earnings Per Share
2.672.652.652.842.602.32
EPS Growth
0.60%-0.18%-6.80%9.27%11.97%26.86%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
Commercial Segment
51,694
Intersegment Offset
-354.9
Others
1,129
Total
52,468

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7,81111,48210,88610,9268,8967,316
Total Debt
506.36516.28845.95547.5515.13701.93
Net Cash (Debt)
7,30410,96510,04010,3788,3816,614
Net Cash Growth
-8.57%9.22%-3.26%23.83%26.72%21.97%
Net Cash Per Share
9.6814.5313.3113.7611.118.77

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
305.742,0061,6592,7272,3951,957
Capital Expenditures
-67.26-68.19-130.77-145.12-129.78-95.07
Free Cash Flow
238.481,9371,5282,5822,2651,862
Free Cash Flow Growth
-82.56%26.76%-40.80%13.96%21.64%51.09%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
6.52%6.58%7.10%8.03%8.39%7.79%
Operating Margin
3.79%3.86%4.16%4.77%5.10%4.42%
Pretax Margin
4.88%4.96%5.24%5.90%5.91%5.26%
Profit Margin
3.77%3.81%3.95%4.32%4.32%3.77%
FCF Margin
0.45%3.69%3.02%5.20%4.98%4.01%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.8000.8000.8000.8540.7820.700
Dividend Per Share Growth
0%0%-6.32%9.21%11.71%27.27%
Dividend Yield
2.83%2.86%2.47%3.24%3.11%2.52%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
10.6110.8612.9110.0610.7213.56
Forward PE
10.1810.2510.718.9110.0112.87
P/FCF Ratio
89.5411.2016.898.379.2912.77
PS Ratio
0.400.410.510.440.460.51